Birchbrook’s AbbVie ABBV Stock Holding History

Birchbrook’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$151K	Buy	578 +1	+0.2%	+$256	0.07%	90
2026 Q2	$145K	Sell	577 -1,400	-71%	-$301K	0.07%	95
2026 Q1	$430K	Buy	1,977 +1	+0.1%	+$222	0.21%	58
2025 Q4	$452K	Hold	1,976	–	–	0.23%	55
2025 Q3	$457K	Buy	1,976 +1	+0.1%	+$204	0.24%	54
2025 Q2	$367K	Buy	1,975 +1	+0.1%	+$186	0.2%	57
2025 Q1	$414K	Hold	1,974	–	–	0.23%	52
2024 Q4	$351K	Buy	1,974 +1	+0.1%	+$184	0.2%	51
2024 Q3	$390K	Buy	1,973 +26	+1%	+$4.85K	0.22%	51
2024 Q2	$334K	Buy	1,947 +1	+0.1%	+$166	0.2%	52
2024 Q1	$354K	Buy	1,946 +1	+0.1%	+$172	0.21%	50
2023 Q4	$301K	Buy	+1,945	New	+$284K	0.2%	56

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Birchbrook's ABBV Position: Q3 2026 in Review

Birchbrook increased its AbbVie (ABBV) stake by 0.17% in Q3 2026, buying an estimated $256 and bringing the position to 578 shares worth $151K. The position accounts for 0.07% of the portfolio, ranked #90.

Birchbrook first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $457K in Q3 2025. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Birchbrook held 578 shares of AbbVie worth $151K as of Q3 2026.
Birchbrook bought 1 AbbVie share in Q3 2026, an estimated $256.
AbbVie made up 0.07% of Birchbrook's portfolio in Q3 2026, its #90 holding.
Birchbrook first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
Birchbrook's AbbVie position peaked at $457K in Q3 2025.
1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.